Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib

Gouji Toyokawa, Fumihiko Hirai, Eiko Inamasu, Tsukihisa Yoshida, Kaname Nosaki, Tomoyoshi Takenaka, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Fingerprint Dive into the research topics of 'Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib'. Together they form a unique fingerprint.